Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In vitro screening of kinase inhibitor drug candidates in human whole blood
NL-OMON47365Active, not recruiting
- Sponsor
- Farmacologie
- Start
- Sep 2015
- Countries
- 1
01
Overview
Open-label trial in cancer and autoimmune disease (2 arms), sponsored by Farmacologie. Primary endpoints: Percent inhibition of stimulated signaling responses and Frequency of dead cells. Started Sep 2015; status: active, not recruiting.
02
Conditions
cancerautoimmune disease
Beyond the preview
Go deeper on NL-OMON47365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47365.